Cart
sales@molnova.com
Thiazolidinone-Derivatives-1
CAS No. 136272-75-8
Thiazolidinone-Derivatives-1( —— )
Catalog No. M26480 CAS No. 136272-75-8
Thiazolidinone-Derivatives-1 inhibits the secretion of gastric acid and can be used in research on the treatment of gastric and duodenal ulcers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 59 | Get Quote |
|
| 25MG | 88 | Get Quote |
|
| 50MG | 128 | Get Quote |
|
| 100MG | 178 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameThiazolidinone-Derivatives-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionThiazolidinone-Derivatives-1 inhibits the secretion of gastric acid and can be used in research on the treatment of gastric and duodenal ulcers.
-
DescriptionThiazolidinone-Derivatives-1 inhibits the secretion of gastric acid and can be used in research on the treatment of gastric and duodenal ulcers.(In Vitro):Thiazolidinone-Derivatives-1 is an antiulcer agent with a gastric acid secretion-inhibiting effect.
-
In VitroThiazolidinone-Derivatives-1 is extracted from patent WO/1991/008203, compound example 1. Thiazolidinone-Derivatives-1 shows a gastric acid secretion-inhibiting effect and therefore, is useful for the treatment of gastric and duodenal ulcers.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number136272-75-8
-
Formula Weight218.27
-
Molecular FormulaC11H10N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1SCCN1Cc1ccccc1C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Amplia Therapeutics completes single-dose study of AMP945
molnova catalog
related products
-
WKYMVM 2TFA(187986-1...
WKYMVM 2TFA is a N-formyl peptide receptor (FPR1) agonist.Neutrophils are activated by WKYMVM through FPRL1 and that FPRL2 is a chemotactic receptor transducing signals in myeloid cells.Using blood samples withdrawn from 28 AL patients and 31 healthy controls, found that, in the absence of exogenous WKYMVm, WKYMVm receptor and bactericidal activity did not differ between patients and controls.?
-
Fenchlonine
4-Chloro-DL-phenylalanine is a pharmaceutical intermediate.
-
Isoscopoletin
6-Hydroxy-7-methoxycoumarin is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 6, 7-dimethoxy-2h-chromen-2-one.
